Research paper(+)-and (−)-phenazocine (cas 127-35-5) enantiomers: Evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects

Add time:09/09/2019    Source:sciencedirect.com

cis-N-Substituted N-normetazocine enantiomers possess peculiar pharmacological profiles. Indeed, dextro enantiomers bind with high affinity σ1 receptor while opposite enantiomers bind opioid receptors. In spite of their stereochemistry, cis-N-2-phenylethyl N-normetazocine (phenazocine) enantiomers showed mixed opioid/σ1 receptor profiles and a significant in vivo analgesia. To the best of our knowledge, there is no information available regarding the evaluation of σ1 pharmacological profile in the antinociceptive effects of (+)- and (−)-phenazocine. Therefore, the present study was designed to ascertain this component by in vitro and in vivo studies.In particular, we tested the σ1 affinity of both enantiomers by a predictive binding assay in absence or presence of phenytoin (DPH). Our results showed that DPH (1 mM) did not increase the σ1 receptor affinity of (+)-and (−)-phenazocine (Ki = 3.8 ± 0.4 nM, Ki = 85 ± 2.0 nM, respectively) suggesting a σ1 antagonist profile of both enantiomers. This σ1 antagonistic component of two phenazocine enantiomers was corroborated by in vivo studies in which the selective σ1 receptor agonist PRE-084, was able to unmask their σ1 antagonistic component associated with the opioid activity.The σ1 antagonistic component of (+)- and (−)-phenazocine may justify their analgesic activity and it suggests that they may constitute useful lead compounds to develop new ligands with this dual activity.

We also recommend Trading Suppliers and Manufacturers of phenazocine (cas 127-35-5). Pls Click Website Link as below: cas 127-35-5 suppliers

Prev:A validated LC–MS/MS assay for the simultaneous determination of periplocin and its two metabolites, Periplocymarin (cas 127-32-2) and periplogenin in rat plasma: Application to a pharmacokinetic study
Next:phenazocine (cas 127-35-5))